N232S, G741R and D778G β-cardiac myosin mutants, implicated in familial hypertrophic cardiomyopathy, do not disrupt myofibrillar organisation in cultured myotubes  by Miller, Gaynor et al.
Correspondence
N232S, G741R and D778G
L-cardiac myosin mutants,
implicated in familial hypertrophic
cardiomyopathy, do not disrupt
myo¢brillar organisation in
cultured myotubes
Gaynor Millera, Melanie Colegraveb;1, Michelle Peckhama;*
First published online 29 November 2000
The heart disease familial hypertrophic cardiomyopathy
(FHC) a¡ects up to 0.2% of the population and is the largest
cause of sudden death in young adults (reviewed in [1]). It is
characterised by hypertrophy of cardiac myocytes, disarray of
muscle ¢bres, and an increase in connective tissue. It is caused
by a mutation in one of a number of cytoskeletal proteins that
make up the muscle sarcomere, including myosin, C-protein,
troponin-T and I, K-tropomyosin and the ventricular light
chains.
About 15^30% of families with FHC carry mutations in the
gene for L-cardiac myosin heavy chain (L-MHC), for which
over 50 di¡erent point mutations are known. In common with
other class II conventional myosins, L-cardiac myosin consists
of two heavy chains and two pairs of light chains. The N-
terminal globular region (catalytic domain) that binds nucle-
otide and actin is connected to the ¢lament forming tail
through a lever arm, consisting of an K-helical region to which
the light chains bind. In FHC, mutation hot spots are found
in regions of the myosin that bind actin and nucleotide, and in
the converter domain, or fulcrum, thought to be important for
transmitting conformational changes in the catalytic domain
to the lever arm, which rotates during force production.
It is not clear whether the L-MHC mutants can directly
cause myo¢brillar disarray. Expression of the R403Q muta-
tion, the best studied, causes myo¢brillar disarray in cultured
feline cardiomyocytes but not in rat [2]. Mutant mice carrying
the equivalent mutation in K-cardiac myosin show the ex-
pected FHC phenotype, but do not develop myo¢brillar dis-
array until about 15 weeks of age (reviewed in [1]). A second
FHC mutation, R249Q, assembles normally into muscle sar-
comeres in rat cardiomyocytes [2].
Given that we know that L-MHC mutants result in myo¢-
brillar disarray, it is important to ¢nd out whether any of the
known mutations can directly cause disarray as demonstrated
for other myosin mutations not associated with FHC [3], by
interfering with myo¢brillogenesis in a dominant negative
fashion. To address this question, we stably expressed wild
type (WT) and three di¡erent FHC mutant myosins that
have not been studied in vivo before, in cultured mouse my-
oblasts (H2kb-tsA58, see [4]), and investigated their e¡ects on
myo¢brillogenesis. Two of these were in the region of myosin
thought to act as a fulcrum (G741R, D778G) and one was
close to the nucleotide binding pocket (N232S). We used my-
oblasts that did not normally express L-MHC when di¡eren-
tiated into myotubes, as determined by Western blotting, im-
muno£uorescence and enzyme-linked immunosorbent assay
using L-MHC speci¢c antibodies [5]. A full length L-MHC
cDNA (kind gift of Prof. Vosberg) was used, and expressed
using the CMV promoter. We transfected cells by electropo-
ration, and, for WT and each of the mutants, we analysed one
out of 24 clones recovered, which had the highest expression
levels of L-MHC, in detail. Expression of WT L-MHC using a
mouse embryonic MHC promoter, cloned in this laboratory
(unpublished results), gave similar results to those using the
CMV promoter in myotubes (data not shown).
The constitutive CMV promoter drove expression of
L-MHC in proliferating myoblasts, which normally only ex-
press non-muscle myosins [4]. Immunostaining showed that
each of the three FHC mutant myosins assembled into ¢bre
like structures in the cytoplasm, demonstrating their ability to
form ¢laments in a non-muscle environment (data not
shown). However, the presence of L-MHC in proliferating
myoblasts did not interfere with di¡erentiation into myotubes.
After di¡erentiating the myoblasts for 5 days, we found
that myo¢brillogenesis in myotubes that expressed N232S,
G741R or D778G L-MHC mutants was indistinguishable
from those that expressed WT L-MHC. Staining with an
anti-all skeletal myosin antibody (A1025) showed that regular
arrays of muscle sarcomeres were visible in many of the my-
otubes (data not shown). Furthermore, the expressed WT and
mutant L-MHCs assembled into muscle sarcomeres, and co-
localised with the endogenous embryonic myosin (Fig. 1), in a
manner indistinguishable from each other. The staining for
embryonic myosin showed a single band for each sarcomere,
as expected, as the epitope for this antibody is in the tail
domain (see [5]). The staining for the expressed L-MHC
showed two bands for each sarcomere, with a gap in staining
in the middle of the sarcomere even though the epitope for
this antibody is also in the tail domain. This may suggest that
the cardiac myosin is preferentially adding in at the ends of
the embryonic myosin ¢laments.
These data also show that heterologous expression of
L-cardiac MHC in itself does not disrupt sarcomere assembly,
as might be expected, as expression of L-MHC increases the
overall levels of myosin expressed in the myotubes. Semi-
quantitative estimates of the approximate levels of L-MHC
expression by Western blotting showed that expression levels
were roughly similar for all of the clones, and less than 0.5%
of the total protein (amount of L-cardiac myosin (Wg) per 100
Wg total protein, mean þ S.E.M. (n) was as follows: WT,
0.17 þ 0.05 (6); N232S, 0.34 þ 0.11 (6); G741R, 0.29 þ 0.08
(6); D778G, 0.39 þ 0.15 (5)).
In summary, the data presented here suggest that none of
the three mutant L-MHCs investigated (N232S, G741R and
D778G) disrupts myo¢brillogenesis, and all three mutants are
capable of assembling into muscle sarcomeres. This suggests
that they are unlikely to cause the myo¢brillar disarray seen in
FHC, by directly interfering with myo¢brillogenesis. Together
with the results from a similar, previous study [2], for the two
FHC mutations R204Q and R403Q, we can conclude that it is
unlikely that the majority of the FHC mutants cause myo¢-
brillar disarray in this way.
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As none of the mutants so far looked at interfered with
nascent myo¢brillogenesis, we think that myo¢brillar disarray
is more likely to arise from a change in the contractile proper-
ties of the cardiomyocytes. However, it is not clear how this
occurs. Some evidence suggests that the contractile properties
of FHC mutants are reduced compared to WT myosin. This
‘hypo-contractility’ would lead to a compensatory hypertro-
phy (reviewed in [1]). Other evidence suggests that cardiac
myocytes become hyper-contractile, directly leading to hyper-
trophy (reviewed in [1]). A smooth muscle MHC carrying a
Fig. 1. Confocal images for myosin staining in 5 day old myotubes, transfected with WT L-MHC (A^C), the mutant N232S (D^F), the mutant
N741R (G^I) and the mutant D778G (J^L). The left hand column (A, D, G and J) shows staining with anti-embryonic myosin antibody
(F1652; IgG1), the middle column (B, E, H and K) staining with anti-cardiac myosin antibody (A4840; IgM) and the right hand column (C,
F, I and L) shows the resultant merged images, where F1652 is shown as green, and A4840 as red (areas of co-localisation show up as yellow/
orange). Myotubes were ¢xed using ice-cold methanol, and staining procedures, £uorescent and confocal microscopy were as described [4].
IgG1 and IgM speci¢c secondary antibodies (Serotec) were used to detect F1652 and A4840 staining, respectively. Scale bar 10 Wm.
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mutation equivalent to D778G, and expressed and puri¢ed
using a baculovirus system [6], increased the actin ¢lament
velocity in an in vitro motility assay by 50% compared to
WT. Its actin-activated ATPase activity was also higher sug-
gesting that hypertrophy is an adaptive response to increased
ATP consumption [6]. One di⁄culty in interpreting many of
these studies is that the FHC mutations are often duplicated
into smooth muscle MHC, and do not use L-MHC.
In conclusion, our results support the idea that the FHC
myosin mutants do not directly disrupt myo¢brillogenesis. It
is more likely that a change in contractile function causes the
myo¢brillar disarray observed in FHC. It will be important to
con¢rm whether particular FHC mutations cause hypo- or
hyper-contractility.
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